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ABSTRACT: Arrays of subnanoliter wells (nanowells)
provide a useful system to isolate single cells and analyze
their secreted proteins. Two general approaches have emerged:
one that uses open arrays and local capture of secreted
proteins, and a second (called microengraving) that relies on
closed arrays to capture secreted proteins on a solid substrate,
which is subsequently removed from the array. However, the
design and operating parameters for eﬃcient capture from
these two approaches to analyze single-cell secretion have not
been extensively considered. Using numerical simulations, we analyzed the operational envelope for both open and closed
formats, as a function of the spatial distribution of capture ligands, their aﬃnities for the protein, and the rates of single-cell
secretion. Based on these analyses, we present a modiﬁed approach to capture secreted proteins in-well for highly active secreting
cells. This simple method for in-well detection should facilitate rapid identiﬁcation of cell lines with high speciﬁc productivities.
The number of techniques for single-cell analysis that rely onmicrofabricated systems has expanded rapidly. Several
approaches have been developed to monitor cell−cell
interactions,1,2 cell proliferation and diﬀerentiation,3 and protein
secretion4−7 with single-cell resolution. In particular, the use of
arrays of subnanoliter wells (nanowells) for the characterization
of cells secreting antibodies or other proteins have shown great
potential for accelerating the discovery of novel antigen-speciﬁc
antibodies2,8,910 evaluating immunological responses,11 and
selecting clonal cell lines with high speciﬁc productivities.12,13
Conventional methods for analyzing populations of cells, such
as Enzyme Linked Immunospot (ELISpot) and ﬂow cytometry,
provide single-cell resolution of secreted proteins, but they are
often destructive in nature. Single-cell analysis based on arrays of
nanowells oﬀers several advantages over traditional assays,
including control of mechanical and environmental cues,14,15
the ability to follow cellular responses over long time scales
(days),16 and the ability to recover cells of interest,6,17 among
others. To date, two distinct approaches to capture and quantify
proteins secreted from cells isolated on arrays of nanowells have
emerged. Microengraving involves a conﬁguration wherein the
wells are closed (for short intervals, ∼1−3 h) with a glass slide
supporting immobilized capture antibodies (Figure 1A).6−8,14
Other reported approaches have used open arrays of wells
modiﬁed with capture antibodies either on the bottoms of the
wells5 or on the planar surfaces between wells10 to bind proteins
released from cells over hours to days of incubation (see Figure
1B, as well as Figure S1 in the Supporting Information). Capture
of analytes at or near the surface of the nanowells relies on
principles similar to ELISpot, with the added advantage that
isolating cells in individual wells allows the analysis of both
secreted proteins and cell cytometry, as well as subsequent
recovery of speciﬁc cells by microscopy and manipulation.
While both conﬁgurations have demonstrated useful measure-
ments of secretion from single cells, relatively little consideration
has been given to how the diﬀerent underlying physical principles
for each may govern their operational range, sensitivity, and
suitability for various applications. We have previously
considered the time-dependent mass transfer of proteins
secreted from cells during microengraving, as well as their
accumulation on a substrate by aﬃnity binding, using numerical
simulations.6 Here, we have expanded our computational
analysis to examine further both open and closed conﬁgurations
of arrays of nanowells for capturing secreted proteins. We
considered how operating parameters such as incubation time,
ligand aﬃnity, rates of secretion, and spatial geometries impacted
the time required to reach steady-state conditions and the overall
eﬃciency (deﬁned by the maximum total quantities of proteins
captured). Based on these computational analyses, we
demonstrate a modiﬁed approach for improved open-well
capture of secreted proteins that oﬀers improved capture
eﬃciencies. Together, these data and analyses provide a
conceptual framework and predicted theoretical eﬃciency for
the design and use of arrays of nanowells as a bioanalytical tool
for detecting single-cell protein secretion.
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■ MATERIALS AND METHODS
Computational Analysis of Analyte Transport and
Binding. Cells were assumed to secrete proteins (e.g., cytokine
or antibody) at a constant rate:
κ=N ttotal (1)
where Ntotal is the total number of molecules, κ is a constant that
describes the rate of secretion, and t is the time secreted proteins
diﬀuse radially into the media. We note that the rate of secretion
for a live cell likely ﬂuctuates over time, depending on extrinsic
factors, such as the quality of its environment, as well as intrinsic
factors, including its secretory capacity, state of activation, and
stage in the cell cycle.18 Nonetheless, assuming a constant rate in
this model is useful for understanding the relationship between
the quantities of protein secreted and that captured on the
surface, and evaluating the upper bounds of analyte binding over
the course of an experiment.








where C is the analyte concentration and D is the diﬀusion
coeﬃcient.
The capture surface was assumed to be coated uniformly with
antibodies against the analyte (either cytokines or antibodies)
and the binding reaction described by a reversible equilibrium
process:






where B is the concentration of free binding sites at the surface
and Cs is the concentration of analyte−antibody complex at the
surface. The parameters kon and koff are the association and
dissociation constants, respectively. Nonuniformity of the
capture reagent at the molecular scale could aﬀect these
predictions, although we note that the imaging systems typically
employed for assessing the capture of analytes experimentally
average over length scales many-fold larger (approximately
square micrometers). Other gross artifacts related to the
manufacturing and preparation of the devices that could aﬀect
the interfacial uniformity such as bubbles, protein aggregations,
and topographical imperfections are outside the scope of this
analysis.
The walls of the device were modeled as impermeable to the
proteins captured. Polydimethylsiloxane (PDMS) is permeable
to certain gases, such as oxygen,19 but is impermeable to proteins
and hydrophilic small molecules.20 Permeability is also generally
reduced upon plasma treatment used to create hydroxyl groups,
making the exposed surface hydrophilic.19 Nonspeciﬁc binding
to the surface of the wells was considered negligible (Kd in the
millimolar range) compared to speciﬁc capture (Kd ≈ 10−0.1
nM). Typically, the capture surface is blocked with BSA before
adding the suspension of cells, and the media used for cell culture
contains bovine serum (typically 10%). In this conﬁguration, the
total concentration of proteins (predominantly serum albumin)
greatly exceeds that of speciﬁc analytes. Based on their
abundance and expected equilibrium partitioning at the
interfaces, these other proteins would be expected to represent
the most prevalent ones adsorbed nonspeciﬁcally on the surfaces
of the well.
Figure 1. Schematic of (A) microengraving and (B) in-well capture assays for single-cell analysis of secreted proteins. Arrays of nanowells allow selective
capture of analytes at the surface modiﬁed with capture antibody or ligand. The spatial addresses of the wells allow identiﬁcation of speciﬁc cells secreting
proteins of interest, and their subsequent recovery. In panel A, microengraving involves a closed conﬁguration wherein the wells are sealed with a solid
substrate such as a glass slide coated with an aﬃnity ligand that captures secreted protein. The solid substrate is removed and further processed using
ﬂuorescently labeled antibodies. Panel B illustrates in-well capture of secreted proteins from single cells. The secreted protein is captured on the surface
of the wells coated with aﬃnity ligands. All steps from incubation with ﬂuorescent detection antibodies and washing are performed on the device
containing the cells. In panel (C), the scale for the simulations in this work is expressed in units of pmol/m2, which is convenient to generalize secretion
of any protein with diﬀerent molecular weights. For convenience, we have included the scales representing concentrations in units of fg/μg2 for the case
of antibodies (∼150 kDa) and cytokines (∼15 kDa).
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The reaction and diﬀusion at the surface is described by a ﬁrst-
order Langmuir adsorption model, where the diﬀusive ﬂux (−n ⃗·
(−D∇C)) is balanced against the reaction rate.
− ⃗· − ∇ = ∂∂
= ∇ + − −
n D C
t
k C B k
( )
Cs
Ds Cs ( Cs) Cs2 on 0 off (4)
where B0 is the initial concentration of immobilized capture
ligand or antibodies (i.e., binding sites) and (B0−Cs) describes
the density of available binding sites. Since the capture antibodies
are immobilized on the surface, the diﬀusion term (Ds) becomes
equal to zero. Thus, the equation describing the boundary
conditions is given by
− ⃗· − ∇ = ∂∂
= − −n D C
t
k C B k( )
Cs
( Cs) Cson 0 off (5)
For these simulations, we assumed that the binding of
antibody and analyte occurs at a 1:1 stoichiometry. Furthermore,
we assumed that the initial concentration (at t = 0) of free analyte
(C) and bound analyte (Cs) are negligible (Cs = 0, C = 0). The
boundary condition for the edges of the medium above the wells
was C = 0, assuming that the concentration far from a secreting
cell is negligible. All simulations were performed using
COMSOL Multiphysics 4.3. The range of values for all
parameters used for the simulations was taken from the literature
and summarized in Table 1. The scale used in these simulations
to represent the amount of bound proteins is expressed in units
of pmol/m2; however, we have included a scale comparing the
values in terms of pmol/m2 to fg/μm2 in Figure 1C to simplify
any conversion to mass of protein bound to the surface.
Preparation of Arrays of Nanowells. Arrays of nanowells
were manufactured by injecting polydimethylsiloxane (PDMS,
Dow Corning) prepared at a 10:1 base/catalyst weight ratio into
a custom-built mold encasing a silicon master micropatterned
with SU-8 by photolithography. Arrays of nanowells were cured
at 70 °C for 4 h. Each array comprised 72 × 24 blocks, each
containing a 7 × 7 (50 μm × 50 μm × 50 μm) subarray of
nanowells with a center-to-center distance of 100 μm, a 12 × 12
(30 μm × 30 μm × 30 μm) subarray with a center-to-center
distance of 60 μm, or a 24 × 24 (15 μm × 15 μm × 15 μm)
subarray with a center-to-center distance of 30 μm. The
elastomeric arrays adhered directly to a 3 in. × 1 in. glass slide
forming a 1-mm-thick layer. The PDMS device was plasma
oxidized for 90−120 s using a plasma cleaner (Harrick Plasma
Model PDC-001, 115 V) before adsorption of the antigen.
Cell Culture. A hybridoma cell line (No. 099-01, obtained
from the Statens Serum Institut) secreting anti-ovalbumin (anti-
OVA) IgG was cultured in DMEM (10% FBS, 100 U/mL
penicillin and 100 mg/mL streptomycin), as described
previously.8 Cells were split every 2−3 days under sterile
conditions. The cells were centrifuged at 1500 rpm and
resuspended in fresh media to remove excess secreted antibodies
(that accumulate over days in culture) before each experiment.
The devices were placed in a four-well slide processing dish
(Nunc, Thermo Scientiﬁc) and rinsed with media. After
aspirating the media, ∼300 μL of the cells (at 106 cells/mL in
media) were deposited on the array by slowly pipetting the
volume over the entire area of the device that had been previously
blocked with bovine serum albumin (BSA) (see below). Cells
were allowed to settle for 5 min; excess cells were removed by
gently aspirating and replacing media.
In-Well Capture and Detection of Secreted Proteins
from Single Cells. Chicken ovalbumin (Pierce, Thermo
Scientiﬁc) was immobilized on the surface of the arrays by
incubation overnight with a concentration of 500 μg/mL in
phosphate-buﬀered saline (PBS) and then blocked with 1 mg/
mL PBS/BSA for 30 min before adding cells. After the cells were
seeded into the array and incubated for 2 h, the cells were rinsed
with media and incubated with ﬂuorescently labeled (Alexa Fluor
488) goat anti-mouse IgG (H+L) (Molecular Probes, Life
Technologies) at a concentration of 3 μg/mL and calcein violet
(Molecular Probes, Life Technologies) to label live cells in PBS
containing 1 mg/mL BSA for 30 min at room temperature. The
cells were rinsed ﬁrst with PBS, then with media, and imaged.
The elastomeric substrates were covered with a No. 2 Lifter slip
and imaged using an automated, inverted epiﬂuorescence
microscope (Axio Observer, 10×/0.3 NA objective; Carl Zeiss,
Jena, Germany) with an EM-CCD camera (ImagEM;
Hamamatsu Photonics, Hamamatsu, Japan).
Microengraving. Epoxy-functionalized glass slides (Super
epoxy 2, Arrayit Corporation) were coated with 100 μg/mL
ovalbumin in PBS overnight at 4 °C and then rinsed with PBS
and blocked with 1 mg/mL BSA/PBS for 30 min. After
incubation of the cell-loaded array, the ovalbumin-coated glass
slide was then placed onto the loaded array for printing. The
microarray and glass slide were held together by compression in a
hybridization chamber (Agilent Technologies, G2534A) and
incubated for 2 h at 37 °C with 5% CO2 as described previously.
6
The glass slide was then separated from the array and placed in
PBS. After microengraving, slides were incubated for 30 min with
blocking buﬀer (PBS, 3% w/v milk powder and 0.05% (v/v)
Tween-20), washed with PBST (PBS + 0.05% v/v Tween-20),
and then incubated with ﬂuorescent antibodies (Alexa Fluor 488
goat anti-mouse IgG) at 2 μg/mL for 45 min at 25 °C. The slides
were washed with PBST and PBS, rinsed brieﬂy with water, and
dried with a N2 stream. Slides were scanned using a Genepix
4200AL microarray scanner (Molecular Devices). The median
ﬂuorescence intensity of each element was analyzed using
Genepix Pro. Data extracted from both on-chip cytometry and
printed proteins were matched in Microsoft Excel using unique
identiﬁers assigned to each well within the array. The dataset was
ﬁltered to include wells containing only single cells.
On-Chip Image-Based Cytometry beforeMicroengrav-
ing. Before imaging, cells were stained with calcein violet
(Invitrogen). The cell-loaded arrays of nanowells were mounted
face-up on the microscope with a coverslip placed on top of the
array. Images were acquired on an automated inverted
epiﬂuorescence microscope (Carl Zeiss). Transmitted light and
epiﬂuoresence micrographs were collected block by block. The
resulting collection of images was analyzed using a custom
program to determine the number of cells present in each well
Table 1. Values of Parameters Used in the Finite-Element
Analysis
parameter value
cell diameter 10 μm
density of total binding sites, B0 1 × 10
−9 mol/m2 (ref 21)
dissociation binding constant, Kd =
koff/kon
#1 10 nM (kon = 1 × 10
5 1/(M s),
koff = 1 × 10
−3 s−1)
#2 0.1 nM (kon = 1 × 10
6 1/(M s),
koff = 1 × 10
−4 s−1)
diﬀusion coeﬃcient, D 3 × 10−11 m2/s (ref 22)
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and the mean ﬂuorescent intensity of each label. Only viable cells
(with a calcein ﬂuorescent intensity of more than three standard
deviations above background) were considered for the analysis.
■ RESULTS
Theoretical Analysis of Surface Capture of Proteins on
OpenArrays of Nanowells. Previous reports for the capture of
secreted proteins in an open-well conﬁguration have established
the utility of this format for detecting single-cell secretions. It
remains unclear, however, how the single-cell rates of secretion,
the equilibrium binding constant of the capture antibody, the
dimensions of the wells, and the spatial distribution of the aﬃnity
ligands (capture antibody or ligand) in the wells aﬀect the total
amount of captured analyte and the time scales required to reach
steady state.
We ﬁrst simulated the steady-state spatial distribution of
antibodies secreted from cells as a function of the spatial
distributions of the capture ligands based on published
conﬁgurations.5,8,10 For these analyses, we modeled plasma
cells secreting antibodies; the speciﬁc productivities of these cells
range from 500 molecules/s to 2000 molecules/s.8,23 In the
open-well conﬁguration, secreted proteins are free to diﬀuse into
the surrounding media or adjacent wells as well as bind to the
aﬃnity ligands supported on the substrate. Comparing two
reported conﬁgurations for open-well arrays,5,10 we found that
the interfacial concentration of captured proteins at steady state
was higher when the basal surface of the wells was modiﬁed with
aﬃnity ligands than when only the planar surfaces between wells
were coated (see Figure S1 in the Supporting Information). The
local proximity of the cell to the aﬃnity ligands positioned in-well
and the radial diﬀusion of the analyte into the bulk media
inﬂuence these calculated diﬀerences.
Reported approaches for in-well detection have also used
patterned hydrogels containing polyethylene glycol on the side
walls to minimize nonspeciﬁc capture of the secreted proteins.5
Our initial simulations suggested that uniform coating of the
capture ligand on all sides of the wells should enhance the
retention of secreted proteins in the well, in addition to allowing
a simple method of fabrication. We examined this conﬁguration
further by calculating the interfacial concentrations of captured
protein when the nanowells were uniformly coated with aﬃnity
ligands. In this model, we tested the eﬀects of both the size and
spacing of wells and the aﬃnity of the binding interactions (Kd =
10 nM and Kd = 0.1 nM) (see Figure 2). These simulations
showed 4-fold enhanced retention of analytes (on entire available
binding area) and 2-fold for high aﬃnity ligand, compared to
arrays where only the top planar surfaces support moderate
aﬃnity ligands (see Figure S1 in the Supporting Information).
Themajority of the captured analytes were also spatially conﬁned
to the well, increasing the interfacial concentration. Decreasing
the sizing of the wells from 50 μm to 15 μm in width and depth
only increased the concentration of captured protein in wells by
2.7-fold. Importantly, the interfacial concentrations of protein in
empty wells adjacent to ones with highly active secreting cells
remainedmore than an order of magnitude lower than that in the
well with the secreting cell.
Comparative Analysis of Eﬃciency of In-Well Capture
and Microengraving. Activated B cells (plasma cells and
plasmablasts) as well as optimized cell lines used in
biomanufacturing (e.g., CHO cells) secrete proteins at high
rates, but the range of speciﬁc productivities for these types of
cells are typically 1−2 orders of magnitude higher than that for
other proteins secreted by primary cells (such as cytokines and
chemokines, ∼5−50 molecules/s).6 We calculated how the rates
of single-cell secretion impacted the time required to reach
steady-state conditions and the total amounts of secreted
product captured in both open-well and closed-well (micro-
engraving) formats (see Figure 3). These results show that the
open-well arrangement reaches steady state within 1 h, regardless
of the rate of secretion for moderate aﬃnity ligands, and that the
maximum interfacial concentrations of captured protein varies
strongly with the rates of secretion. For higher aﬃnity ligands,
however, the time required to reach steady state increases.
In contrast, microengraving operates in a nonequilibrium
state.6 The interfacial concentrations increase linearly over a
somewhat wider range of times (0−4+ h, depending on the size
of the well and rates of secretion), and reach higher values than
those possible for the open-well format. Furthermore, at steady
state, the interfacial concentrations are independent of the rates
of secretion (see Figure S2A in the Supporting Information),
although the time required to reach saturation does depend on
the rate of secretion. However, the diﬀerences between the two
conﬁgurations (open and closed wells) diminish signiﬁcantly, as
the rates of secretion increase and the aﬃnity of the capture
reagent increases (from Kd = 10 nM to Kd = 0.1 nM) (see Figure
3, as well as Figure S2B in the Supporting Information).
In these simulations, we have assumed an ideal position of the
cell at the center of the basal surface of the wells. We had
previously considered how alternate locations of the cell within
the well (for example, a corner) could introduce variation to the
captured analytes by microengraving and found no signiﬁcant
diﬀerence.6 Here, we also examined whether or not the
positioning of the cell could introduce variations in captured
amounts using in-well detection (open system). In this
conﬁguration, we found there was also no signiﬁcant eﬀects on
the total average concentration of captured analyte over the
capture surface of the well when a cell was positioned in the
corner of a well (see Figure S3 in the Supporting Information).
However, we note that minute gradients in concentration can
Figure 2. Theoretical surface distribution of bound analyte from single-
cell secretions captured in-well. Finite-element simulations of secreted
proteins captured on the surface of the nanowells as a function of the
volume of wells and aﬃnity of the capture ligand when proteins are
secreted at a rate of 1000 molecules/s.
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form (for in-well detection) in the proximity of the cells, forming
aminor halo eﬀect (as seen in Figure 4). In addition, the eﬀects of
nonspeciﬁc binding have been found to be negligible (see Figure
S4 in the Supporting Information).
Detection of Secreted Antigen-Speciﬁc Antibodies
Inside Nanowells. Our numerical simulations indicated that
microengraving oﬀers enhanced sensitivity to the detection of
secreted proteins across a wide range of single-cell rates, but that
Figure 3. Time-dependent interfacial concentrations of proteins captured from a single cell in open and closed conﬁgurations. Plots depict the average
surface concentration of secreted analyte bound to the capture surface for both microengraving and in-well capture, as a function of the rates of secretion
and dimensions of the nanowells. The equilibrium association-binding constant used for these plots are (A) Kd = 10 nM and (B) Kd = 0.1 nM.
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in-well detection should provide biased detection of cells with
high rates of secretion. Such bias would highlight cells with high
speciﬁc productivitiesa criterion that should facilitate the
selection of both hybridomas producing antigen-speciﬁc anti-
bodies and cell lines for bioprocess development.13 We sought to
demonstrate that a device containing arrays of nanowells is
experimentally amenable for the eﬃcient detection of secreted
proteins when the surfaces of the wells are uniformly coated with
capture antibodies (as depicted in Figure 1B). We used a mouse
hybridoma line (099-01) that produces monoclonal antibodies
speciﬁc for chicken ovalbumin. Ovalbumin was ﬁrst adsorbed
onto the surfaces of an array of nanowells. Then cells were
deposited onto the array from a suspension in a manner that
favored single-cell occupancies in the wells. The loaded array was
incubated for 2 h at 37 °C. A ﬂuorescently labeled anti-mouse
IgG antibody was then added and further incubated with the cells
for 30 min at room temperature. The array was rinsed gently to
avoid washing away or repositioning cells. This method allowed
the enumeration of both the number of viable cells in each well
and the detection of captured ovalbumin-speciﬁc antibodies by
automated epiﬂuorescence microscopy (EM) (see Figure 4).
The cells remained viable during the course of the experiment,
including the labeling and washing steps at room temperature.
We found that the incubation of 2 h yielded detectable quantities
of captured antibodies, consistent with the time predicted from
the numerical simulations to reach equilibrium in the open-well
format. Also consistent with the models, the ﬂuorescent signal
predominantly localized to the bottom surface and sidewalls of
the nanowells, even though the entire surface of the array bore
antigen. This localization within the wells created sharp, clear
patterns of ﬂuorescence, which facilitated simple image analysis
to establish the spatial address of wells of interest. The observed
patterns of captured antibodies also matched those predicted for
antibodies with high aﬃnities in the numerical simulations; the
aﬃnity of the anti-OVA antibody is 0.11 nM, as determined by
surface plasmon resonance.11
We then compared the dynamic range of signal for captured
proteins in-well to that determined by microengraving (see
Figure 5). Microengraving provided ﬁne resolution of the
variations in the rates of secretion, with a 3-fold greater dynamic
range, compared to in-well detection. Both measures were
performed using 16-bit detectors and imaging parameters
individually optimized to maximize the signals detected.
However, we note that, because of constraints of the thickness
of the arrays used, the systems upon which the data were
collected were diﬀerentin-well detection used an EM-CCD
and xenon lamp for epiﬂuorescent microscopy while the
microengraved array was imaged with a photomultiplier tube
(PMT) and laser excitation in a microarray scanner. Never-
theless, both methods demonstrate an ability to enumerate cells
with the highest speciﬁc productivities, and the results for each
method agree well with the predictions from the numerical
simulations. Together, these results support the computational
framework developed here to facilitate the design and under-
standing of the speciﬁc conﬁguration of assays in nanowells for
in-well capture and establishes the utility of uniform coatings of
capture ligands for in-well detection of single-cell secreted
proteins.
■ DISCUSSION
In this work, we developed a set of guidelines to aid in the design
of experiments that involve the use of arrays of nanowells to
quantify and analyze proteins secreted from single cells. We
analyzed the transport and binding dynamics of analytes secreted
from single cells, using an array of nanowells for both in-well
capture and microengraving. Based on these analyses, we
presented a modiﬁed method for in-well detection wherein the
entire surface of the array is coated with capture ligands to detect
single-cell secretions. As expected, the two most important
parameters inﬂuencing the eﬃciency of detecting secreted
analytes are the dissociation binding constant (Kd) and the
rates of secretion for the cells. The aﬃnity constant is particularly
important, because the use of suboptimal capture antibodies or
antigens could lead to false negatives.
On one hand, the use of nanowells for in-well capture with a
uniformly coated surface to detect secreted proteins oﬀers
ﬂexibility and ease of use. This conﬁguration eliminates complex
fabrication schemes5,10 and is compatible with a range of molding
methods and materials (e.g., polystyrene) that are more
conducive for mass production than arrays formed with silicone
elastomers. In addition, contrary to other approaches,10 analytes
bind to the sidewalls to create sharp and well-deﬁned spatial
patterns that simplify automated image analysis and concentrate
signal to facilitate the detection of positive wells and high-
throughput data extraction. The single substrate employed for in-
well detection further simpliﬁes post-assay processing and data
integration and, thus, reduces the total time required for the
process. One disadvantage evident from the numerical
simulations is that the maximum signal in open-well conﬁg-
urations is strongly dependent on the rates of secretion, as a
result of persistent diﬀusion of material out of the wells. The
constraints imposed by thermodynamics and mass transport
make the method less useful for quantitative measures. These
features together suggest that the open-well conﬁguration is best-
Figure 4. In-well capture of antigen-speciﬁc antibodies from single cells.
Transmitted light and ﬂuorescent composite micrographs of live cells
(red) labeled with calcein violet and the captured secreted anti-OVA
antibody (green) detected by Alexa 488 anti-mouse IgG in nanowells
uniformly coated with ovalbumin. Scale bar = 30 μm.
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suited for rapid screening of highly productive cells (e.g.,
antibody-secreting cells, manufacturing cell lines), and biases
toward high secretors and high aﬃnity interactions.
On the other hand, microengraving provides a complementary
method for single-cell analysis of secreted proteins. The
temporary conﬁnement of the volume into which proteins are
secreted enhances the sensitivity of the method for low rates of
secretion, and makes the measurements more robust across a
range of dissociation constants for the capture ligand, compared
to open-well conﬁgurations. Microengraving also establishes an
operating condition that expands the dynamic range of
measurements, facilitating quantiﬁcation of the amounts of
secreted protein. The increase in sensitivity and quantitative
potential compensates for the additional time required for
processing and data integration. These features make the method
well-suited for assessing heterogeneous populations of secreting
cells, such as T cells.86,11,14
One possible perturbation introduced in a closed system is that
secretions from the cells could be aﬀected by the local
concentration of analyte or other soluble factors. Sealed wells,
as in the case of microengraving, would also retain higher
concentrations of secreted protein relative to open wells. This
eﬀect could induce signaling mechanisms for feedback (such as
autocrine signaling) that may change cellular processes
(including secretion) over time, and could, therefore, aﬀect the
total amount of proteins available for capture in open versus
closed wells as a result of biological feedback. Nevertheless, this
phenomena will not likely be a concern for the screening of
antibody-secreting cells or when local concentrations of ligands
vastly exceed the numbers of available receptors on the surface of
a single cell.
■ CONCLUSIONS
The computational analyses presented here should aid the design
of bioanalytical assays that rely on arrays of nanowells for
measuring secreted proteins from single cells. The established
framework addresses the thermodynamics and mass transport of
the two common conﬁgurations used in practice. Our results
should provide practical guidance on the operating range and
limitations of each conﬁguration, their expected sensitivities and
optimal incubation times based on rates of secretion and aﬃnity
of the capture reagent, as well as the costs of materials and labor
required, with respect to the objectives of the assay.
■ ASSOCIATED CONTENT
*S Supporting Information
Figure S1 compares the theoretical surface capture of secreted
antibody (from single cells) in the conﬁguration developed in
this report and the conﬁguration previously published. Figure S2
summarizes the theoretical maximum binding of analytes to the
Figure 5. Experimental comparison of in-well capture and microengraving. Intensity distribution of Alexa 488 anti-mouse IgG used to detect secreted
ovalbumin speciﬁc antibodies from the hybridoma cells. (A) Intensity distribution from detected surface captured analyte in the in-well capture
conﬁguration. (B) Intensity distribution obtained by microengraving. The blue histogram represents background ﬂorescence obtained from wells with
no cells; the black histogram shows the mean ﬂuorescent intensities quantiﬁed for wells with single cells (total ﬂuorescence per unit area). Scale bar = 30
μm.
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capture surface in an open system (in-well capture) or closed
system (microengraving) conﬁguration and the half-time to
reach steady-state. Figure S3 analyzes the eﬀects of deviation
from centralized positioning of the cell in the wells. Figure S4
investigates the eﬀects of nonspeciﬁc binding on the capture of
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